Cardiovascular Abnormalities: Clinical Trials

20 trials for Cardiovascular Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 terminated. 20 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 320Terminated 20
Phase 25Terminated 5

Follow Cardiovascular Abnormalities: new trials by email Literature Review of Cardiovascular Abnormalities trials Research Report on Cardiovascular Abnormalities

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
L-citrulline, Plasmalyte A - Ventricular Septal Defect, Atrioventricular Septal Defect
Phase 3TerminatedAsklepion Pharmaceuticals, LLC642022-06-292024-09-19
Specialized Pacing for Patients With Congenital Heart Disease
Closed loop stimulation, Standard rate response - Congenital Heart Disease, Bradycardia Sinus
Phase 2 / Phase 3TerminatedUniversity of California, Los Angeles42021-05-092023-01-20
Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
Propranolol treatment, Placebo - Hereditary Hemorrhagic Telangiectasia, Osler Weber Rendu Disease
Phase 3TerminatedUniversity Hospital, Bordeaux152020-06-232026-06-23
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
macitentan 10 mg - Congenital Heart Disease With Fontan Circulation
Phase 3TerminatedActelion1122019-04-112023-03-07
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
Fenoldopam, 0.9%NS - Patent Ductus Arteriosus (PDA), Acute Kidney Injury (AKI)
Phase 2 / Phase 3TerminatedMedical College of Wisconsin12019-02-062022-09-16
Colchicine in Postoperative Fontan Patients
Colchicine - Single-ventricle, Heart Diseases
Phase 2 / Phase 3TerminatedUniversity of Michigan112018-08-292022-05-09
Acetaminophen vs Indomethacin in Treating hsPDA
Indomethacin, Acetaminophen - Patent Ductus Arteriosus
Phase 3TerminatedUniversity of Tennessee372016-06-012019-12-03
Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Eleclazine, Eleclazine placebo - Long QT Syndrome Type 3
Phase 3TerminatedGilead Sciences412014-12-172018-01-12
Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Bevacizumab, placebo - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 2 / Phase 3TerminatedHospices Civils de Lyon802014-04-012015-11-20
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
Macitentan 10 mg tablet, once daily. - Pulmonary Arterial Hypertension
Phase 3TerminatedActelion2172013-09-102019-04-16
Right to Left Cardiac Shunt Detection
Flow Detection System - Right to Left Shunt, Patent Foramen Ovale
Phase 3TerminatedCardiox Corporation1412012-11-012015-11-13
Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)
Atenolol, Telmisartan - Cardiac Disease
Phase 3TerminatedHamilton Health Sciences Corporation852011-06-012019-09-18
Cardiox Shunt Detection Technology Study
Cardiox FDS - Patent Foramen Ovale
Phase 3TerminatedCardiox Corporation712011-04-012013-01-09
Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
placebo, Losartan - Marfan Syndrome
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris3032008-09-012015-11-04
An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Indomethacin - Patent Ductus Arteriosus
Phase 2 / Phase 3TerminatedUniversity of Calgary92008-08-012016-08-18
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
Sildenafil, Placebo - Pulmonary Arterial Hypertension (PAH)
Phase 3TerminatedCompetence Network for Congenital Heart Defects242007-12-012012-06-06
Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
Dobutamin - Tetralogy of Fallot
Phase 3TerminatedCompetence Network for Congenital Heart Defects532007-11-012012-06-06
Effects of PTH Replacement on Bone in Hypoparathyroidism
PTH 1-34 - Hypoparathyroidism, DiGeorge Syndrome
Phase 3TerminatedNational Institute of Dental and Craniofacial Research (NIDCR)462006-10-302019-08-28
ESCAPE Migraine Trial
PFO Closure with Premere investigational device., Medical management/current medications per standard of care by personal physician. - Migraine Disorders, Heart Septal Defects, Atrial
Phase 3TerminatedAbbott Medical Devices1682005-11-012019-02-04
Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
Enalapril, Placebo - Heart Defects, Congenital, Heart Septal Defects, Ventricular
Phase 3TerminatedUniversity of Utah52004-12-012014-03-13

Narrower conditions

Ductus Arteriosus, Patent (3)  ·  Foramen Ovale, Patent (3)  ·  Eisenmenger Complex (2)  ·  Epistaxis (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)  ·  Heart Septal Defects, Atrial (2)  ·  Heart Septal Defects, Ventricular (2)  ·  Migraine Disorders (2)  ·  Pulmonary Arterial Hypertension (2)  ·  Telangiectasia, Hereditary Hemorrhagic (2)  ·  Univentricular Heart (2)  ·  Acute Kidney Injury (1)  ·  Aortic Aneurysm, Thoracic (1)  ·  Atrioventricular Septal Defect (1)

Broader conditions

Cardiovascular Diseases (20)  ·  Congenital Abnormalities (20)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (20)  ·  Heart Defects, Congenital (16)  ·  Heart Diseases (16)  ·  Heart Septal Defects (5)  ·  Respiratory Tract Diseases (5)  ·  Vascular Diseases (5)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Hemic and Lymphatic Diseases (3)  ·  Abnormalities, Multiple (2)  ·  Arrhythmias, Cardiac (2)  ·  Brain Diseases (2)

Interventions

Indomethacin (2)  ·  macitentan (2)  ·  Acetaminophen (1)  ·  Atenolol (1)  ·  Bevacizumab (1)  ·  Citrulline (1)  ·  Colchicine (1)  ·  Dobutamine (1)  ·  Enalapril (1)  ·  Fenoldopam (1)  ·  Losartan (1)  ·  Parathyroid Hormone (1)  ·  Plasmalyte A (1)  ·  Saline Solution (1)  ·  Sildenafil Citrate (1)

Sponsors

Actelion (2)  ·  Cardiox Corporation (2)  ·  Competence Network for Congenital Heart Defects (2)  ·  Abbott Medical Devices (1)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Gilead Sciences (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Hospices Civils de Lyon (1)  ·  Medical College of Wisconsin (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  University Hospital, Bordeaux (1)  ·  University of Calgary (1)  ·  University of California, Los Angeles (1)  ·  University of Michigan (1)

Countries

United States (13)  ·  France (6)  ·  Canada (5)  ·  Germany (4)  ·  United Kingdom (3)  ·  China (2)  ·  Poland (2)  ·  Australia (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Greece (1)  ·  Israel (1)

Top investigators

Amuchou S Soraisham, MD, DM (1)  ·  Christopher Mastropietro, MD, FCCM (1)  ·  David Dodick, MD (1)  ·  Gurdyal Kalsi, MD, MFPM (1)  ·  Ingram Schulze-Neick, MD (1)  ·  Jeffrey Segar, MD (1)  ·  Judith Therrien, MD (1)  ·  LuAnn Minich, MD (1)  ·  Michael W Jopling, MD (1)  ·  Philipp Beerbaum, MD (1)  ·  Rachel I Gafni, M.D. (1)

Results publications

PMID 18628265, PMID 20619242, PMID 21094951, PMID 21163497, PMID 21315203, PMID 22065264, PMID 23258386, PMID 24223740, PMID 24854626, PMID 25313847, PMID 25653299, PMID 25935877, PMID 26052700, PMID 26168357, PMID 26244949, PMID 26283668, PMID 26672023, PMID 27599328, PMID 39607014, PMID 39625244, PMID 4418268, PMID 6338474, PMID 6343572

NIH funding

2014 (1), 2016 (1), 2018 (1), U01HL068269 (1), U01HL068270 (1), U01HL068279 (1), U01HL068281 (1), U01HL068285 (1), U01HL068288 (1), U01HL068290 (1), U01HL068292 (1)